Previous research has suggested that the p53 mutational spectrum of breast cancer includes high proportions of G:C→T:A transversions, G:C→A:T transitions at CpG sites, and insertions/deletions (Biggs et al. 1993; Goldman and Shields 1998; Greenblatt et al. 1994). This evidence concerns the gene TP53 and breast carcinoma.